Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × ganirelix × 1 year × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 18 Inositol 12 Letrozole 7 Tablets 3 Exercise 3 Estradiol 3 semaglutide 2 maltodextrin 2 drospirenone and ethinyl estradiol combination 2 artenimol 2 Spironolactone 2 Progesterone 2 Magnesium 2 Liraglutide 2 Ethinyl Estradiol 2 Docosahexaenoic Acids 2 Diet Therapy 2 Contraceptives, Oral, Combined 2 Clomiphene 2 Caloric Restriction 2 salicylsalicylic acid 1 mirabegron 1 ganirelix 1 etonogestrel 1 empagliflozin 1 drospirenone 1 cetrorelix 1 Walking 1 Transcranial Direct Current Stimulation 1 Thyroxine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05751252 2025-04-27

SOPKGANI

University Hospital, Lille

Phase EARLY_PHASE1 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡